(Q73659561)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Acute ischemic stroke therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

S L Hickenbottom

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W G Barsan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

379-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Blood pressure during the first minutes of focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Heparin for lacunar stroke in progression

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Intravenous heparin for the prevention of stroke progression in acute partial stable stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Failure of heparin to prevent progression in progressing ischemic infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Factors affecting changes in blood pressure after acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

1 reference

7 January 2021

Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

1 reference

7 January 2021

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Heparin anticoagulation in acute brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Thrombolytic therapy with streptokinase in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Anticoagulation followed by elective carotid surgery in patients with repetitive transient ischemic attacks and high-grade carotid stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

An alternative view of heparin anticoagulation in acute focal brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Acute hypertension after stroke: the scientific basis for treatment decisions.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Usefulness of heparin in initial management of patients with recent transient ischemic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Practice advisory: thrombolytic therapy for acute ischemic stroke--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970198-5

7 January 2021

10.1016/S0733-8619(05)70198-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10757832%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference